The fungal secondary metabolites have become potent biotechnological weapons, and they provide a fantastic diversity of bioactive compounds which are utilized in medicine, agriculture, and industry. In this chapter, the extensive metabolic potential of fungi, especially the filamentous Ascomycota and Basidiomycota will be discussed, along with the advancements in genetics, systems biology,and fermentation engineering that enable us to reach their full potential. Fungi have a historical lifesaving drug record, including penicillin and lovastatin. These are now being re-engineered with advanced technologies including CRISPR/Cas9 and synthetic biology to improve yields, unlock silent gene clusters, or synthesize new molecules. The present chapter explains how early methods such as random mutagenesis and protoplast fusion paved the way to modern strain improvement, which is currently being transformed by targeted genome editing and pathway rewiring. Co-culturing, promoter swapping, and synthetic regulatory circuits enable fine control of metabolite production. Furthermore, the fungal biosynthesis genes are becoming more applicable to scalable and economical hosts due to their heterologous expression in microbial hosts as Pichia pastoris and Bacillus subtilis. Genetic manipulation aside, this chapter also discusses the problems of laboratory-to-industrial scale-up—particular in viscous fungal fermentations. Parameter optimization, such as oxygen transfer, shear stress, nutrient availability, and incorporation of bioprocess modelling have been found vital to repeatable yields at scale. Case studies illustrate how designed strains of Fusarium heterosporum, Trichoderma reesei, and Aspergillus oryzae are opening the route to sustainable biomanufacturing with inexpensive raw materials. In whole, this chapter shows that biology and engineering are coming together in contemporary fungal biotechnology. By utilizing sophisticated instruments and carefully thought-out plans for expansion, fungi are in a strong position to lead the next phase of sustainable innovation in the biosynthesis of natural products.